Advertisement
Review Article| Volume 40, ISSUE 2, P223-235, May 2022

The Management of Agitated Toxidromes

  • Sophie Gosselin
    Correspondence
    Corresponding author. 3120 Boulevard Taschereau, Greenfield Park, Québec, Canada.
    Affiliations
    Centre Intégré de Santé et de Services Sociaux (CISSS), Montérégie-Centre Emergency Department, Hôpital Charles-Lemoyne, 3120 Boulevard Taschereau, Greenfield Park, Québec J4V 2H1, Canada

    Centre Antipoison du Québec, Québec, Canada

    Department of Emergency Medicine, McGill University, Montreal, Québec, Canada
    Search for articles by this author
  • Robert S. Hoffman
    Affiliations
    Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, 455 First Avenue Room 123, New York, NY 10016, USA
    Search for articles by this author
Published:April 05, 2022DOI:https://doi.org/10.1016/j.emc.2022.01.009

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Emergency Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Donlon P.T.
        • Hopkin J.
        • Tupin J.P.
        Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol.
        Am J Psychiatry. 1979; 136: 273-278
        • Asch D.A.
        • Parker R.M.
        The Libby Zion case. One step forward or two steps backward?.
        N Engl J Med. 1988; 318: 771-775
        • Patel N.
        Learning lessons: the Libby Zion case revisited.
        J Am Coll Cardiol. 2014; 64: 2802-2804
        • Klein L.R.
        • Driver B.E.
        • Miner J.R.
        • et al.
        Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department.
        Ann Emerg Med. 2018; 72: 374-385
        • Martel M.L.
        • Driver B.E.
        • Miner J.R.
        • et al.
        Randomized double-blind trial of intramuscular droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department.
        Acad Emerg Med. 2021; 28: 421-434
        • Cole J.B.
        • Stang J.L.
        • DeVries P.A.
        • et al.
        A prospective study of intramuscular droperidol or olanzapine for acute agitation in the emergency department: a natural experiment owing to drug shortages.
        Ann Emerg Med. 2021; 78: 274-286
        • Cole J.B.
        • Moore J.C.
        • Nystrom P.C.
        • et al.
        A prospective study of ketamine versus haloperidol for severe prehospital agitation.
        Clin Toxicol (Phila). 2016; 54: 556-562
        • Cole J.B.
        • Klein L.R.
        • Nystrom P.C.
        • et al.
        A prospective study of ketamine as primary therapy for prehospital profound agitation.
        Am J Emerg Med. 2018; 36: 789-796
        • Martel M.
        • Sterzinger A.
        • Miner J.
        • et al.
        Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
        Acad Emerg Med. 2005; 12: 1167-1172
        • Calver L.
        • Drinkwater V.
        • Gupta R.
        • et al.
        Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial.
        Br J Psychiatry. 2015; 206: 223-228
        • Isbister G.K.
        • Calver L.A.
        • Page C.B.
        • et al.
        Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study.
        Ann Emerg Med. 2010; 56: 392-401 e1
        • Catravas J.D.
        • Waters I.W.
        Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality.
        J Pharmacol Exp Ther. 1981; 217: 350-356
        • Bohnert A.S.
        • Prescott M.R.
        • Vlahov D.
        • et al.
        Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006.
        Addiction. 2010; 105: 1049-1054
        • Marzuk P.M.
        • Tardiff K.
        • Leon A.C.
        • et al.
        Ambient temperature and mortality from unintentional cocaine overdose.
        JAMA. 1998; 279: 1795-1800
        • Wu A.H.
        • McKay C.
        • Broussard L.A.
        • et al.
        National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.
        Clin Chem. 2003; 49: 357-379
        • Moeller K.E.
        • Kissack J.C.
        • Atayee R.S.
        • et al.
        Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens.
        Mayo Clin Proc. 2017; 92: 774-796
        • Kellermann A.L.
        • Fihn S.D.
        • LoGerfo J.P.
        • et al.
        Impact of drug screening in suspected overdose.
        Ann Emerg Med. 1987; 16: 1206-1216
        • Eisen J.S.
        • Sivilotti M.L.
        • Boyd K.U.
        • et al.
        Screening urine for drugs of abuse in the emergency department: do test results affect physicians' patient care decisions?.
        CJEM. 2004; 6: 104-111
        • Tenenbein M.
        Do you really need that emergency drug screen?.
        Clin Toxicol (Phila). 2009; 47: 286-291
        • Lager P.S.
        • Attema-de Jonge M.E.
        • Gorzeman M.P.
        • et al.
        Clinical value of drugs of abuse point of care testing in an emergency department setting.
        Toxicol Rep. 2018; 5: 12-17
        • Connors N.J.
        • Alsakha A.
        • Larocque A.
        • et al.
        Antipsychotics for the treatment of sympathomimetic toxicity: A systematic review.
        Am J Emerg Med. 2019; 37: 1880-1890
        • Marder S.R.
        • Sorsaburu S.
        • Dunayevich E.
        • et al.
        Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
        J Clin Psychiatry. 2010; 71: 433-441
        • Chan E.W.
        • Taylor D.M.
        • Knott J.C.
        • et al.
        Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
        Ann Emerg Med. 2013; 61: 72-81
        • Cole J.B.
        • Moore J.C.
        • Dolan B.J.
        • et al.
        A prospective observational study of patients receiving intravenous and intramuscular olanzapine in the emergency department.
        Ann Emerg Med. 2017; 69: 327-336 e2
        • Martel M.L.
        • Klein L.R.
        • Rivard R.L.
        • et al.
        A large retrospective cohort of patients receiving intravenous olanzapine in the emergency department.
        Acad Emerg Med. 2016; 23: 29-35
        • Williams A.M.
        Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness.
        Ment Health Clin. 2018; 8: 208-213
        • Dundee J.W.
        • Gamble J.A.
        • Assaf R.A.
        Letter: Plasma-diazepam levels following intramuscular injection by nurses and doctors.
        Lancet. 1974; 2: 1461
        • Hung O.R.
        • Dyck J.B.
        • Varvel J.
        • et al.
        Comparative absorption kinetics of intramuscular midazolam and diazepam.
        Can J Anaesth. 1996; 43: 450-455
        • Korttila K.
        • Linnoila M.
        Absorption and sedative effects of diazepam after oral administration and intramuscular administration into the vastus lateralis muscle and the deltoid muscle.
        Br J Anaesth. 1975; 47: 857-862
        • Silbergleit R.
        • Durkalski V.
        • Lowenstein D.
        • et al.
        Intramuscular versus intravenous therapy for prehospital status epilepticus.
        N Engl J Med. 2012; 366: 591-600
        • Welch R.D.
        • Nicholas K.
        • Durkalski-Mauldin V.L.
        • et al.
        Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population.
        Epilepsia. 2015; 56: 254-262
        • Greenblatt D.J.
        • Comer W.H.
        • Elliott H.W.
        • et al.
        Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results. Research Support, U.S. Gov't, Non-P.H.S.
        J Clin Pharmacol. 1977; 17: 490-494
        • Greenblatt D.J.
        • Ehrenberg B.L.
        • Gunderman J.
        • et al.
        Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
        Clin Pharmacol Ther. 1989; 45: 356-365
        • Greenblatt D.J.
        • Ehrenberg B.L.
        • Gunderman J.
        • et al.
        Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam.
        . 1989; 250: 134-140
        • Greenblatt D.J.
        • Joyce T.H.
        • Comer W.H.
        • et al.
        Clinical pharmacokinetics of lorazepam. II. Intramuscular injection. Research Support, U.S. Gov't, Non-P.H.S.
        Clin Pharmacol Ther. 1977; 21: 222-230
        • File S.E.
        • Bond A.J.
        Impaired performance and sedation after a single dose of lorazepam.
        Psychopharmacology (Berl). 1979; 66: 309-313
        • Reves J.G.
        • Fragen R.J.
        • Vinik H.R.
        • et al.
        Midazolam: pharmacology and uses.
        Anesthesiology. 1985; 62: 310-324
        • Barr J.
        • Zomorodi K.
        • Bertaccini E.J.
        • et al.
        A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
        Anesthesiology. 2001; 95: 286-298
        • Lim H.S.
        • Kim S.J.
        • Noh Y.H.
        • et al.
        Exploration of optimal dosing regimens of haloperidol, a D2 Antagonist, via modeling and simulation analysis in a D2 receptor occupancy study.
        Pharm Res. 2013; 30: 683-693
        • Riddell J.
        • Tran A.
        • Bengiamin R.
        • et al.
        Ketamine as a first-line treatment for severely agitated emergency department patients.
        Am J Emerg Med. 2017; 35: 1000-1004
        • Isbister G.K.
        • Calver L.A.
        • Downes M.A.
        • et al.
        Ketamine as rescue treatment for difficult-to-sedate severe acute behavioral disturbance in the emergency department.
        Ann Emerg Med. 2016; 67: 581-587.e1
        • Battaglia J.
        • Moss S.
        • Rush J.
        • et al.
        Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.
        Am J Emerg Med. 1997; 15: 335-340
      1. ACEP Excited Delirium Task Force. White paper report on excited delirium syndrome. 2009;

        • Roppolo L.P.
        • Morris D.W.
        • Khan F.
        • et al.
        Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation).
        J Am Coll Emerg Physicians Open. 2020; 1: 898-907
        • Garriga M.
        • Pacchiarotti I.
        • Kasper S.
        • et al.
        Assessment and management of agitation in psychiatry: expert consensus.
        World J Biol Psychiatry. 2016; 17: 86-128
        • Wilson M.P.
        • Pepper D.
        • Currier G.W.
        • et al.
        The psychopharmacology of agit ation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.
        West J Emerg Med. 2012; 13: 26-34
        • Bouchama A.
        • Knochel J.P.
        Heat stroke.
        N Engl J Med. 2002; 346: 1978-1988
        • Shapiro Y.
        • Alkan M.
        • Epstein Y.
        • et al.
        Increase in rat intestinal permeability to endotoxin during hyperthermia.
        Eur J Appl Physiol Occup Physiol. 1986; 55: 410-412
        • Shih C.J.
        • Lin M.T.
        • Tsai S.H.
        Experimental study on the pathogenesis of heat stroke.
        J Neurosurg. 1984; 60: 1246-1252
        • Yang T.H.
        • Shih M.F.
        • Wen Y.S.
        • et al.
        Attenuation of circulatory shock and cerebral ischemia injury in heat stroke by combination treatment with dexamethasone and hydroxyethyl starch.
        Exp Transl Stroke Med. 2010; 2: 19
        • Shapiro Y.
        • Rosenthal T.
        • Sohar E.
        Experimental heatstroke. A model in dogs.
        Arch Intern Med. 1973; 131: 688-692
        • Douma M.J.
        • Aves T.
        • Allan K.S.
        • et al.
        First aid cooling techniques for heat stroke and exertional hyperthermia: a systematic review and meta-analysis.
        Resuscitation. 2020; 148: 173-190
        • Filep E.M.
        • Murata Y.
        • Endres B.D.
        • et al.
        Exertional heat stroke, modality cooling rate, and survival outcomes: a systematic review.
        Medicina (Kaunas). 2020; 56: 589
        • Weiner J.S.
        • Khogali M.
        A physiological body-cooling unit for treatment of heat stroke.
        Lancet. 1980; 315: 507-509
        • Khogali M.
        • Weiner J.S.
        Heat stroke: report on 18 cases.
        Lancet. 1980; 316: 276-278
        • Proulx C.I.
        • Ducharme M.B.
        • Kenny G.P.
        Effect of water temperature on cooling efficiency during hyperthermia in humans.
        J Appl Physiol. 1985; 94: 1317-1323
        • Laskowski L.K.
        • Landry A.
        • Vassallo S.U.
        • et al.
        Ice water submersion for rapid cooling in severe drug-induced hyperthermia.
        Clin Toxicol (Phila). 2015; 53: 181-184
        • Hoffman R.S.
        • Goldfrank L.R.
        The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail.
        JAMA. 1995; 274: 562-569
        • Shannon M.
        Toxicology reviews: physostigmine.
        Pediatr Emerg Care. 1998; 14: 224-226
        • Pentel P.
        • Peterson C.D.
        Asystole complicating physostigmine treatment of tricyclic antidepressant overdose.
        Ann Emerg Med. 1980; 9: 588-590
        • Tong T.G.
        • Benowitz N.L.
        • Becker C.E.
        Tricyclic antidepressant overdose.
        Drug Intell Clin Pharm. 1976; 10: 711-712
        • Burns M.J.
        • Linden C.H.
        • Graudins A.
        • et al.
        A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
        Ann Emerg Med. 2000; 35: 374-381
        • Watkins J.W.
        • Schwarz E.S.
        • Arroyo-Plasencia A.M.
        • et al.
        The use of physostigmine by toxicologists in anticholinergic toxicity.
        J Med Toxicol. 2015; 11: 179-184
        • Arens A.M.
        • Shah K.
        • Al-Abri S.
        • et al.
        Safety and effectiveness of physostigmine: a 10-year retrospective review.
        Clin Toxicol (Phila). 2017; 13: 1-7
        • Boley S.P.
        • Olives T.D.
        • Bangh S.A.
        • et al.
        Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center.
        Clin Toxicol (Phila). 2019; 57: 50-55
        • Wang G.S.
        • Baker K.
        • Ng P.
        • et al.
        A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
        Clin Toxicol (Phila). 2020; : 1-13https://doi.org/10.1080/15563650.2020.1854281
        • Nisijima K.
        • Yoshino T.
        • Yui K.
        • et al.
        Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome.
        Brain Res. 2001; 890: 23-31
        • Graudins A.
        • Stearman A.
        • Chan B.
        Treatment of the serotonin syndrome with cyproheptadine.
        J Emerg Med. 1998; 16: 615-619
        • Lappin R.I.
        • Auchincloss E.L.
        Treatment of the serotonin syndrome with cyproheptadine.
        N Engl J Med. 1994; 331: 1021-1022
        • Fox A.W.
        More on rhabdomyolysis associated with cocaine intoxication.
        N Engl J Med. 1989; 321: 1271
        • Hadad E.
        • Cohen-Sivan Y.
        • Heled Y.
        • et al.
        Clinical review: treatment of heat stroke: should dantrolene be considered?.
        Crit Care. 2005; 9: 86-91